|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$73,768.72 |
2.22% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$73,068.55 |
2.20% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$71,982.96 |
2.17% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$71,147.04 |
2.14% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$70,932.42 |
2.14% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$70,951.65 |
2.14% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$70,709.35 |
2.13% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$70,766.08 |
2.13% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$70,279.24 |
2.12% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,481.73 |
2.12% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$70,295.08 |
2.12% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$70,104.44 |
2.11% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$69,768.37 |
2.10% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$69,644.19 |
2.10% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$69,520.85 |
2.09% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$69,220.48 |
2.08% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$69,220.68 |
2.08% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$68,981.43 |
2.08% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,976.91 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
298 |
$69,180.70 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$68,603.11 |
2.07% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$68,626.25 |
2.07% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$68,397.93 |
2.06% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$68,295.79 |
2.06% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$68,388.90 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,481.89 |
2.06% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$68,418.61 |
2.06% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$68,221.63 |
2.05% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$67,713.30 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,268.14 |
2.03% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,075.50 |
2.02% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$66,968.85 |
2.02% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$67,182.24 |
2.02% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$66,575.40 |
2.01% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$66,891.57 |
2.01% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$66,637.28 |
2.01% |
| Waters Corporation |
WAT |
941848103 |
147 |
$66,689.49 |
2.01% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$66,463.10 |
2.00% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$65,889.55 |
1.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$65,568.26 |
1.97% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$65,360.54 |
1.97% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,901.25 |
1.95% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$64,741.25 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,878.00 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$63,185.18 |
1.90% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$59,234.40 |
1.78% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$56,368.67 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,241.26 |
1.66% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,555.94 |
1.34% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.74% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|